Cargando…

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ) resistance problem. FQ revealed to be equally active on CQ-sensitive and CQ-resistant Plasmodium falciparum la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, Fraisse, Laurent, Pradines, Bruno, Brocard, Jacques, Khalife, Jamal, Dive, Daniel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395321/ https://www.ncbi.nlm.nih.gov/pubmed/16464254 http://dx.doi.org/10.1186/1475-2875-5-11

Ejemplares similares

In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border
por: Barends, Marion, et al.
Publicado: (2007)

Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action
por: Dubar, Faustine, et al.
Publicado: (2008)

The antimalarial ferroquine: from bench to clinic
por: Biot, C., et al.
Publicado: (2011)

In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014)

Ferroquine, the next generation antimalarial drug, has antitumor activity
por: Kondratskyi, Artem, et al.
Publicado: (2017)

Ferroquine and its derivatives: New generation of antimalarial agents
por: Wani, Waseem A., et al.
Publicado: (2015)

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
por: Mombo-Ngoma, Ghyslain, et al.
Publicado: (2011)

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
por: McCarthy, James S., et al.
Publicado: (2016)

Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
por: Gansane, Adama, et al.
Publicado: (2023)

Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria
por: Salim, Malinda, et al.
Publicado: (2019)

Genome wide in silico analysis of Plasmodium falciparum phosphatome
por: Pandey, Rajan, et al.
Publicado: (2014)

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
por: Adoke, Yeka, et al.
Publicado: (2021)

Analysis of the interactome of the Ser/Thr Protein Phosphatase type 1 in Plasmodium falciparum
por: Hollin, Thomas, et al.
Publicado: (2016)

Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion
por: Salim, Malinda, et al.
Publicado: (2020)

Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use
por: Noranate, Nitchakarn, et al.
Publicado: (2007)

Investigations on the Novel Antimalarial Ferroquine in Biomimetic Solutions Using Deep UV Resonance Raman Spectroscopy and Density Functional Theory
por: Domes, Robert, et al.
Publicado: (2023)

In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
por: Dormoi, Jérome, et al.
Publicado: (2014)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Characterization of GEXP15 as a Potential Regulator of Protein Phosphatase 1 in Plasmodium falciparum
por: Mansour, Hala, et al.
Publicado: (2023)

PhosphoTyrosyl Phosphatase Activator of Plasmodium falciparum: Identification of Its Residues Involved in Binding to and Activation of PP2A
por: Vandomme, Audrey, et al.
Publicado: (2014)

Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
por: Vinayak, Sumiti, et al.
Publicado: (2010)

Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites
por: Ekala, Marie-Thérèse, et al.
Publicado: (2007)

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

Peptides derived from Plasmodium falciparum leucine-rich repeat 1 bind to serine/threonine phosphatase type 1 and inhibit parasite growth in vitro
por: Pierrot, Christine, et al.
Publicado: (2018)

Bioorganometallic Chemistry and Malaria
por: Biot, Christophe, et al.
Publicado: (2010)

Plasmodium falciparum proteome changes in response to doxycycline treatment
por: Briolant, Sébastien, et al.
Publicado: (2010)

Characterization of a Protein Phosphatase Type-1 and a Kinase Anchoring Protein in Plasmodium falciparum
por: Lenne, Astrid, et al.
Publicado: (2018)

Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
por: Fall, Bécaye, et al.
Publicado: (2016)

Genetic Structure of Plasmodium falciparum and Elimination of Malaria, Comoros Archipelago
por: Rebaudet, Stanislas, et al.
Publicado: (2010)

SSRPrimer and SSR Taxonomy Tree: Biome SSR discovery
por: Jewell, Erica, et al.
Publicado: (2006)

In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum
por: Andriantsoanirina, Valérie, et al.
Publicado: (2011)

Plasmodium falciparum with Multidrug Resistance 1 Gene Duplications, Senegal
por: Pascual, Aurélie, et al.
Publicado: (2013)

Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals
por: Eisen, Damon P, et al.
Publicado: (2007)

Kmer-SSR: a fast and exhaustive SSR search algorithm
por: Pickett, Brandon D, et al.
Publicado: (2017)

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
por: Foguim, Francis Tsombeng, et al.
Publicado: (2020)

Isolation and characterization of SSR and EST‐SSR loci in Chamaecyparis formosensis (Cupressaceae)
por: Huang, Chiun‐Jr, et al.
Publicado: (2018)

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
por: Pascual, Aurélie, et al.
Publicado: (2013)

Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
por: Gaillard, Tiphaine, et al.
Publicado: (2018)

Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014
por: Voumbo-Matoumona, Dominique Fatima, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_net6hl1u7sulc8fv0gnma7kgn6